Technical Analysis for JNCE - Jounce Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 3.8 -20.00% -0.95
JNCE closed down 20.0 percent on Friday, January 18, 2019, on 2.06 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical JNCE trend table...

Date Alert Name Type % Chg
Jan 18 Fell Below 20 DMA Bearish 0.00%
Jan 18 Fell Below 50 DMA Bearish 0.00%
Jan 18 New Downtrend Bearish 0.00%
Jan 18 Stochastic Sell Signal Bearish 0.00%
Jan 18 Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Jan 18 Wide Range Bar Range Expansion 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Down 3 Days in a Row Weakness 0.00%
Jan 17 1,2,3 Pullback Bullish Bullish Swing Setup -20.00%

Older signals for JNCE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States.
Is JNCE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.25
52 Week Low 2.66
Average Volume 338,477
200-Day Moving Average 8.4114
50-Day Moving Average 4.1406
20-Day Moving Average 3.9605
10-Day Moving Average 4.599
Average True Range 0.4029
ADX 30.63
+DI 20.9913
-DI 25.8698
Chandelier Exit (Long, 3 ATRs ) 3.7913
Chandelier Exit (Short, 3 ATRs ) 3.8687
Upper Bollinger Band 5.5048
Lower Bollinger Band 2.4162
Percent B (%b) 0.45
BandWidth 77.985103
MACD Line 0.1819
MACD Signal Line 0.1276
MACD Histogram 0.0543
Fundamentals Value
Market Cap 122.19 Million
Num Shares 32.2 Million
EPS 0.03
Price-to-Earnings (P/E) Ratio 126.67
Price-to-Sales 5.66
Price-to-Book 2.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.30
Resistance 3 (R3) 5.46 5.11 5.05
Resistance 2 (R2) 5.11 4.73 5.04 4.97
Resistance 1 (R1) 4.46 4.50 4.29 4.30 4.88
Pivot Point 4.11 4.11 4.03 4.04 4.11
Support 1 (S1) 3.46 3.73 3.29 3.30 2.72
Support 2 (S2) 3.11 3.50 3.04 2.63
Support 3 (S3) 2.46 3.11 2.55
Support 4 (S4) 2.30